Abstract
This paper provides an outline of the development and growth of EUROCAT, the European network of congenital anomaly registers. In recent years the network has been through a period of transition and change. The Central Register of data has transferred from the Ulster University to the EU Joint-Research-Centre, Ispra, Italy.
The benefits of combining data from across Europe, from different populations and countries are described by the uses to which these data can be put. These uses include:
. surveillance of anomalies at a local, regional or pan-European level
. pharmacovigilance
. registration of rare diseases
New studies and projects are underway, including EUROlinkCAT (a Horizon 2020 funded data-linkage project), promising a fruitful future in further research of congenital anomalies.
This is a preview of subscription content, access via your institution.
Similar content being viewed by others
Change history
25 October 2018
The published online version contains the following errors: On the cover page "JRC Management Committee" – should be corrected to JRC-EUROCAT Management Committee. In the authors list under the title, same as above, "JRC Management Committee" should be corrected to JRC-EUROCAT Management Committee
25 October 2018
The published online version contains the following errors: On the cover page "JRC Management Committee" ��� should be corrected to JRC-EUROCAT Management Committee. In the authors list under the title, same as above, "JRC Management Committee" should be corrected to JRC-EUROCAT Management Committee
25 October 2018
The published online version contains the following errors: On the cover page "JRC Management Committee" ��� should be corrected to JRC-EUROCAT Management Committee. In the authors list under the title, same as above, "JRC Management Committee" should be corrected to JRC-EUROCAT Management Committee
References
Barisic I, Odak L, Loane M, Garne E, Wellesley D, Calzolari E, Dolk H, Addor MC, Arriola L, Bergman J, Bianca S (2013) Fraser syndrome: epidemiological study in a European population. Am J Med Genet A 161(5):1012–1018
Barisic I, Boban L, Greenlees R, Garne E, Wellesley D, Calzolari E, Addor MC, Arriola L, Bergman JE, Braz P, Budd JL (2014a) Holt Oram syndrome: a registry-based study in Europe. Orphanet J Rare Dis 9(1):156
Barisic I, Odak L, Loane M, Garne E, Wellesley D, Calzolari E, Dolk H, Addor MC, Arriola L, Bergman J, Bianca S (2014b) Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in Europe. Eur J Hum Genet 22(8):1026
Barisic I, Boban L, Loane M, Garne E, Wellesley D, Calzolari E, Dolk H, Addor MC, Bergman JE, Braz P, Draper ES (2015) Meckel–Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe. Eur J Hum Genet 23(6):746
Boyd P, Barisic I, Haeusler M, Loane M, Garne E, Dolk H (2011a) Paper 1: The EUROCAT network: organization and processes. Birth Defects Res A 91:2–15 [full text]
Boyd P, Haeusler M, Barisic I (2011b) EUROCAT report 9: surveillance of congenital anomalies in Europe 1980-2008. Birth Defects Res A 91:S1 [full text]
Boyle B, Morris JK, McConkey R, Garne E, Loane M, Addor MC, Gatt M, Haeusler M, Latos-Bielenska A, Lelong N, McDonnell R (2014) Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening. BJOG Int J Obstet Gynaecol 121(7):809–820
Boyle B, Addor MC, Arriola L, Barisic I, Bianchi F, Csáky-Szunyogh M, de Walle HE, Dias CM, Draper E, Gatt M and Garne E (2017) Estimating global burden of disease due to congenital anomaly: an analysis of European data. Arch Dis Child Fetal Neonatal Ed, pp.fetalneonatal-2016
Busby A, Armstrong B, Dolk H, Armstrong N, Haeusler M, Berghold A, Gillerot Y, Baguette A, Gjergja R, Barisic I, Christiansen M (2005) Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20(3):393–402
Charlton R, Neville A, Jordan S, Pierini A, Damase-Michel C, Klungsoyr K, Nybo Andersen A-M, Vinkel Hansen A, Gini R, Bos HJ, Puccini A, Hurault-Delarue C, Brooks C, de Jong-van den Berg L, de Vries C (2014) Healthcare databases in Europe for studying medicine use and safety during pregnancy. Pharmacoepidemiol Drug Saf [Full Text ] 23:586–594
De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357(2):135–142
Dolk H, Loane M, Garne E, European Surveillance of Congenital Anomalies (EUROCAT) Working Group (2011) Congenital heart defects in Europe. Circulation 123(8):841–849
Dolk H, Loane M, Teljeur C, Densem J, Greenlees R, McCullough N, Morris J, Nelen V, Bianchi F, Kelly A (2015) Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system. Eur J Epidemiol 30(11):1153–1164
EUROCAT (2013) EDMP user guide. Retrieved August 15, 2017, from EUROCAT: http://www.eurocat-network.eu/aboutus/datacollection/edmp/edmpuserguide
EUROCAT (2013) EUROCAT special report: actions towards European environmental surveillance: feasibility of environmental linkage. EUROCAT Central Registry, University of Ulster. [full text]
EUROCAT (2014) EUROCAT special report: sources of information of medication use in pregnancy. EUROCAT Central Registry, University of Ulster. [full text
EUROCAT (2016) EUROCAT guide 1.4. Retrieved August 15, 2017, from EUROCAT: www.eurocat-network.eu/aboutus/datacollection/guidelinesforregistration/guide1_4
Garne E, Loane M, Wellesley D, Barisic I, Eurocat Working Group (2009) Congenital hydronephrosis: prenatal diagnosis and epidemiology in Europe. J Pediatr Urol 5(1):47–52
Garne E, Dolk H, Loane M, Wellesley D, Barisic I, Calzolari E, Densem J (2011) Paper 5: surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases. Birth Defects Res A 91(S1):S44–S50
Khoshnood B, Greenlees R, Loane M, Dolk H (2011) Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A 91(S1):S16–S22
Khoshnood B, Loane M, De Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E, Garne E (2015) Long term trends in prevalence of neural tube defects in Europe: population based study. Bmj 351:h5949
Loane M, Dolk H, Bradbury, a EUROCAT Working Group (2007) Increasing Prevalence of Gastroschisis in Europe 1980–2002: A Phenomenon Restricted to Younger Mothers? Paediatr Perinat Epidemiol 21:363–369 [Abstract]
Loane M, Dolk H, Kelly A, Teljeur C, Greenlees R, Densem J, a EUROCAT Working Group (2011) Paper 4: EUROCAT statistical monitoring: identification of ten year trends of congenital anomalies in Europe. Birth Defects Res A 91:S31–S43. https://doi.org/10.1002/bdra.20778
López-Camelo JS, Orioli IM, Dutra MG, Nazer-Herrera J, Rivera N, Ojeda ME (2005) Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 135:120–125
Martin S, De la Cruz J, Lanzoni M, Nicholl C (2016) Transfer of the central database and coordinating activities of EUROCAT to the JRC. ISBN 978-92-79-63771-1 see also JRC science hub https://ec.europa.eu/jec. last accessed 15th August 2017
Mathews TJ, National Center for Health Statistics (2007) Trends in spina bifida and anencephalus in the United States, 1991–2005. National Center for Health Statistics, Hyattsville https://www.cdc.gov/nchs/data/hestat/spine_anen/spine_anen.htm -accessed 24th August 2017
Morris JK, Rankin J, Garne E, Loane M, Greenlees R, Addor MC, Arriola L, Barisic I, Bergman JE, Csaky-Szunyogh M, Dias C (2016) Prevalence of microcephaly in Europe: population based study. bmj 354:i4721
Neville AJ, de Walle HEK (2010) Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. Gynaecol Forum 15(4):16–20
Pirastu R, Ancona C, Iavarone I, Mitis F, Zona A, Comba P (2010) SENTIERI Project. Mortality study of residents in Italian polluted sites: evaluation of the epidemiological evidence. Epidemiol Prev 34(5–6):1–96
Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B (2008) Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Research Part A: Clinical and Molecular Teratology 82(4):211–216
Teljeur C, Kelly A, Loane M, Densem J, Dolk H (2015) Using scan statistics for congenital anomalies surveillance: the EUROCAT methodology. Eur J Epidemiol 30(11):1165–1173
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Tucker, F.D., Morris, J.K., on behalf of the JRC Management Committee. et al. EUROCAT: an update on its functions and activities. J Community Genet 9, 407–410 (2018). https://doi.org/10.1007/s12687-018-0367-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-018-0367-3